Provectus Biopharmaceuticals, Inc. (QB)
Ticker Symbol: USOTC:PVCT
OTC Market Tier: OTCQB
CIK Number: 0000315545
Security Type: Common Stock
PVCT Address: 10025 Investment Drive
Suite 250
Knoxville, Tennessee 37932
PVCT Country: USA
PVCT Phone: (866) 594-5999
PVCT Fax #: 866-998-0005
Website: http://www.provectusbio.com
Description: Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer and liver cancer. Provectus investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for psoriasis. In addition, Provectus has begun a Phase 3 trial as a therapy for metastatic melanoma. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus, please visit the Company's website at www.provectusbio.com.
SIC Code / Description: 2834 / Pharmaceutical preparations
Shares Authorized: 1,000,000,000
Shares Outstanding: 386,491,975
Shares Outstanding Date: 07/11/2019
Shares Holder Count: 876
Shares Holder Date: 04/01/2019
Market Capitalization: $ 26,843,672.29
Key Executives: Dominic Rodrigues - Vice Chairman
Number of Employees: 3
Incorporation State: DE
Incorporation Country: USA
Incorporation Year: 2002
Auditor: Marcum LLP
Auditor Address: 750 Third Ave
11th Floor
New York, NY 10017
United States
Auditor Website: http://www.marcumllp.com
IR Firm: N/A
Legal Counsel: Baker Donelson Bearman Caldwell & Berkowitz
Legal Counsel Address: 211 Commerce Street
211 Commerce Street
Nashville, TN 37201
USA
Legal Counsel Website: www.bakerdonelson.com
Fiscal Year End: 12/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: Broadridge Financial Solutions, Inc.
TA Address: 1717 Arch Street
Suite 1300
Philadelphia, PA 19103
USA
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 911,415
Short Date: 06/28/2019
Closing MMID: 8
BFCMmid: 7
Tier ID: 10
Status: Active


Your Recent History
USOTC
PVCT
Provectus ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.